Zhejiang Medicine Co Ltd (600216) — Free Cash Flow Generation Index
Zhejiang Medicine Co Ltd (600216) has a Free Cash Flow Generation Index of 0.88x as of September 2025. Free cash flow of CN¥610.74 Million represents 1% of operating cash flow (CN¥690.77 Million). See how liquid is Zhejiang Medicine Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Medicine Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Zhejiang Medicine Co Ltd across 27 annual periods. Explore Zhejiang Medicine Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Medicine Co Ltd. For the full company profile including market capitalisation, see Zhejiang Medicine Co Ltd (600216) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.76x | CN¥1.44 Billion | CN¥1.89 Billion | CN¥446.47 Million | ▲ +74.8% |
| 2024 | 0.44x | CN¥534.15 Million | CN¥1.22 Billion | CN¥689.14 Million | ▲ +270.4% |
| 2023 | -0.26x | CN¥-162.56 Million | CN¥634.31 Million | CN¥796.87 Million | ▲ +70.7% |
| 2022 | -0.87x | CN¥-455.39 Million | CN¥520.60 Million | CN¥975.99 Million | ▼ -604.6% |
| 2021 | 0.17x | CN¥197.05 Million | CN¥1.14 Billion | CN¥939.60 Million | ▼ -69.8% |
| 2020 | 0.57x | CN¥721.37 Million | CN¥1.26 Billion | CN¥535.35 Million | ▲ +303.1% |
| 2019 | -0.28x | CN¥-126.38 Million | CN¥447.25 Million | CN¥573.63 Million | ▼ -216.5% |
| 2018 | 0.24x | CN¥140.61 Million | CN¥579.91 Million | CN¥439.30 Million | ▲ +283.5% |
| 2017 | -0.13x | CN¥-66.52 Million | CN¥503.47 Million | CN¥569.99 Million | ▲ +2.7% |
| 2016 | -0.14x | CN¥-45.63 Million | CN¥336.14 Million | CN¥381.76 Million | ▲ +97.7% |
| 2015 | -5.80x | CN¥-618.42 Million | CN¥106.54 Million | CN¥724.96 Million | ▼ -622.4% |
| 2014 | -0.80x | CN¥-441.86 Million | CN¥549.90 Million | CN¥991.76 Million | ▲ +1.1% |
| 2013 | -0.81x | CN¥-532.38 Million | CN¥655.09 Million | CN¥1.19 Billion | ▼ -375.5% |
| 2012 | -0.17x | CN¥-138.01 Million | CN¥807.49 Million | CN¥945.50 Million | ▼ -127.5% |
| 2011 | 0.62x | CN¥568.17 Million | CN¥912.75 Million | CN¥344.58 Million | ▼ -30.0% |
| 2010 | 0.89x | CN¥1.17 Billion | CN¥1.32 Billion | CN¥145.90 Million | ▼ -0.7% |
| 2009 | 0.90x | CN¥1.31 Billion | CN¥1.47 Billion | CN¥153.13 Million | ▲ +0.5% |
| 2008 | 0.89x | CN¥1.07 Billion | CN¥1.20 Billion | CN¥130.27 Million | ▲ +173.2% |
| 2007 | 0.33x | CN¥74.30 Million | CN¥227.67 Million | CN¥153.37 Million | ▲ +168.7% |
| 2006 | -0.47x | CN¥-80.48 Million | CN¥169.51 Million | CN¥249.99 Million | ▲ +96.2% |
| 2005 | -12.60x | CN¥-316.79 Million | CN¥25.14 Million | CN¥341.93 Million | ▼ -3544.1% |
| 2004 | -0.35x | CN¥-37.20 Million | CN¥107.60 Million | CN¥144.80 Million | ▲ +64.9% |
| 2003 | -0.98x | CN¥-65.17 Million | CN¥66.20 Million | CN¥131.37 Million | ▲ +88.1% |
| 2002 | -8.25x | CN¥-190.69 Million | CN¥23.13 Million | CN¥213.81 Million | ▼ -3550.0% |
| 2001 | -0.23x | CN¥-22.19 Million | CN¥98.25 Million | CN¥120.44 Million | ▲ +97.9% |
| 2000 | -10.69x | CN¥-113.11 Million | CN¥10.58 Million | CN¥123.69 Million | ▼ -802.3% |
| 1998 | -1.18x | CN¥-68.37 Million | CN¥57.72 Million | CN¥126.08 Million | — |